Evidence map›Paper›PMID 36913168›Full record

ArticleInternational urology and nephrology2023

Recent trends in the prescription of opioids in the emergency department in patients with urolithiasis.

Spencer S Liem, Timothy Demus, Alexandra Perez, Dhaval Jivanji, Crystal Y Lee, Kevin A George, Alejandra Perez, Luigi Cubeddu, Jorge F Pereira

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Spencer S LiemMount Sinai Medical Center, Columbia University Division of Urology, 4302 Alton Road, Suite 540, Miami Beach, FL, 33140, USA.
Timothy DemusMount Sinai Medical Center, Columbia University Division of Urology, 4302 Alton Road, Suite 540, Miami Beach, FL, 33140, USA.
Alexandra PerezDepartments of Socio-Behavioral-Administrative Pharmacy, and Pharmaceutical Sciences, Nova Southeastern University, Davie, FL, USA.
Dhaval JivanjiHerbert Wertheim College of Medicine at Florida International University, Miami, FL, USA.
Crystal Y LeeSidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
Kevin A GeorgeHerbert Wertheim College of Medicine at Florida International University, Miami, FL, USA.
Alejandra PerezMount Sinai Medical Center, Columbia University Division of Urology, 4302 Alton Road, Suite 540, Miami Beach, FL, 33140, USA.
Luigi CubedduDepartments of Socio-Behavioral-Administrative Pharmacy, and Pharmaceutical Sciences, Nova Southeastern University, Davie, FL, USA.
Jorge F PereiraMount Sinai Medical Center, Columbia University Division of Urology, 4302 Alton Road, Suite 540, Miami Beach, FL, 33140, USA. jpereira625@gmail.com.
Mount Sinai Medical Center · USFlorida International University · USNova Southeastern University · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePain management is central in the treatment of urolithiasis. We aimed to estimate the impact of the 2017 Department of Health and Human Services declaration of an opioid crisis on prescribing patterns of opioids and NSAIDs in emergency department visits for urolithiasis.

methodsThe National Health Ambulatory Medical Care Survey (NHAMCS) was queried for emergency department visits of adults with a diagnosis of urolithiasis. The association between urolithiasis and narcotic and NSAIDs prescription patterns was evaluated and compared at pre-declaration (2014-2016) to post-declaration (2017-2018) periods.

resultsOpioids were prescribed in about 211 million (41.1%) out of 513 million emergency department visits, over a 5-year period. Diagnosis of urolithiasis accounted for 1.9% of the visits (6.0 million). The use of opioids was higher in urolithiasis (82.7%) compared to non-urolithiasis diagnosis (40.3%), as well as the use of multiple opioids per visit (p < 0.01 for all). There was an overall decrease in opioid prescriptions in the post-declaration period, - 4.3% for urolithiasis (p = 0.254) and - 5.6% for non-urolithiasis visits (p < 0.05). A decrease in the use of hydromorphone (- 47.5%. p < 0.001), an increase in the use of morphine (+ 59.7% p = 0.006), and an increase of 'other' opioids (+ 98.8%, p < 0.041), were observed. Opioids combined with NSAIDs comprised 72.6% of the opioid prescriptions and 62.3% of all analgesic prescriptions in visits with urolithiasis diagnosis.

conclusionsThe use of opioids when managing urolithiasis decreased 4.3% after the crisis declaration; however, statistically are not different from pre-declaration numbers. Most often, opioids were prescribed with NSAIDs in urolithiasis patients.

Indexed as

AnalgesicsAnalgesics, OpioidAdultAnti-Inflammatory Agents, Non-SteroidalEmergency Service, HospitalHumansPractice Patterns, Physicians'PrescriptionsAnalgesicsAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalAnalgesicsOpioidsPainRenal colicUrolithiasis

Identifiers

PMID36913168
OpenAlexW4324017685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.